Related Experiment Video
Updated: Aug 12, 2026
In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
Evidence for a tumour suppressive function of APRG1 in breast cancer
A C A Leris1, T R Roberts, W G Jiang
1St George's Hospital, London, UK.
Introduction:
Deletion mapping studies have shown that genes in the region 3p21.3 are often deleted in epithelial malignancies. Although the regions deleted differ between individual cancers there appears to be a specificity for the type of malignancy produced. As a result this area of chromosome 3 is thought to contain multiple tumour suppressor genes. The present study concentrates on one gene in that region, APRG1. This gene codes for a protein, which has been implicated in cell membrane interactions. The aim was to determine using quantitative PCR whether the levels of this gene were negatively correlated with clinical outcome in breast cancer.
Methods:
One hundred and twenty tumour tissues and 33 normal tissues were analyzed. Levels of transcription of APRG1 were determined using real-time quantitative PCR. APRG1 expression was normalized against CK19. Levels of expression were analyzed against staging, nodal involvement, grade, distant metastasis and survival over a 6 year follow up period.
Results:
Levels of APRG1 mRNA were lower in malignant tissues. They fell further with increasing stage using the TNM classification This became statistically significant when TNM stages 3 and 4 were compared to TNM 1 (p = 0.0046, p = 0.04, t-test). They were lower in those with positive nodes although this did not reach statistical significance. There was a statistically significant reduction in APRG1 in grade 3 tumours cf. grade 1 (p = 0.0081). APRG1 expression was highly negatively correlated with progressive disease: alive with metastasis (p = 0.0069), local recurrence (p = 0.0055), died of breast cancer (p = 0.11), all progressive disease (p = 0.035).
Conclusion:
This study shows a compelling trend for APRG1 transcription levels to be lower in malignant tissues and lower still in those patients who develop progressive disease. There was also a statistically significant difference in APRG1 levels between grade 3 and grade 1 tumours. These results are highly suggestive of APRG1 acting as a tumour suppressor gene.
Insights
Lower levels of APRG1 gene expression were observed in breast cancer tissues and correlated with poorer clinical outcomes, suggesting APRG1 may function as a tumor suppressor gene.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Genes in chromosome region 3p21.3 are frequently deleted in epithelial cancers.
- This region is thought to harbor multiple tumor suppressor genes.
- APRG1, a gene in 3p21.3, is involved in cell membrane interactions.
Purpose of the Study:
- To investigate the correlation between APRG1 gene expression levels and clinical outcomes in breast cancer.
- To determine if APRG1 acts as a tumor suppressor gene in breast cancer.
Main Methods:
- Quantitative PCR was used to measure APRG1 mRNA levels in 120 tumor and 33 normal breast tissues.
- APRG1 expression was normalized to CK19.
- Expression levels were analyzed against tumor stage, nodal involvement, grade, metastasis, and survival over 6 years.
Main Results:
- APRG1 mRNA levels were significantly lower in malignant tissues compared to normal tissues.
- Lower APRG1 expression correlated with advanced TNM stages (3 & 4 vs. 1) and higher tumor grade (3 vs. 1).
- Reduced APRG1 levels were associated with progressive disease, including metastasis and local recurrence.
Conclusions:
- APRG1 transcription levels are decreased in breast tumors and correlate with adverse clinical outcomes.
- The findings strongly suggest APRG1 functions as a tumor suppressor gene in breast cancer.
- Significant differences in APRG1 levels were noted between different tumor grades.
Related Concept Videos
02:23Abnormal Proliferation
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...